Arkolith/Insider Trading/CHRO/Form 4/A

Francis Knuettel II

CEO, Pres., CFO Treas & SectyChromocell Therapeutics Corp (CHRO) · full profile →Form 4/A · filed Jun 18, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 21, 2024Grant(A)3K——25K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001753926-24-001139) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML